22-41230182-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_031488.5(L3MBTL2):c.2049G>A(p.Ser683Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000316 in 1,578,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
L3MBTL2
NM_031488.5 synonymous
NM_031488.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.44
Genes affected
L3MBTL2 (HGNC:18594): (L3MBTL histone methyl-lysine binding protein 2) Enables methylated histone binding activity. Predicted to be involved in negative regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including ectoderm development; regulation of histone modification; and stem cell proliferation. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
CHADL (HGNC:25165): (chondroadherin like) Enables collagen binding activity and collagen fibril binding activity. Involved in negative regulation of collagen fibril organization. Located in collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 22-41230182-G-A is Benign according to our data. Variant chr22-41230182-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2681366.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L3MBTL2 | NM_031488.5 | c.2049G>A | p.Ser683Ser | synonymous_variant | 17/17 | ENST00000216237.10 | NP_113676.2 | |
CHADL | NM_138481.2 | c.2263-452C>T | intron_variant | ENST00000216241.14 | NP_612490.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L3MBTL2 | ENST00000216237.10 | c.2049G>A | p.Ser683Ser | synonymous_variant | 17/17 | 1 | NM_031488.5 | ENSP00000216237.5 | ||
CHADL | ENST00000216241.14 | c.2263-452C>T | intron_variant | 1 | NM_138481.2 | ENSP00000216241.9 |
Frequencies
GnomAD3 genomes AF: 0.000273 AC: 40AN: 146652Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
40
AN:
146652
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251292Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135868
GnomAD3 exomes
AF:
AC:
36
AN:
251292
Hom.:
AF XY:
AC XY:
16
AN XY:
135868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000320 AC: 458AN: 1431556Hom.: 0 Cov.: 34 AF XY: 0.000320 AC XY: 228AN XY: 711464
GnomAD4 exome
AF:
AC:
458
AN:
1431556
Hom.:
Cov.:
34
AF XY:
AC XY:
228
AN XY:
711464
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000273 AC: 40AN: 146652Hom.: 0 Cov.: 30 AF XY: 0.000182 AC XY: 13AN XY: 71262
GnomAD4 genome
AF:
AC:
40
AN:
146652
Hom.:
Cov.:
30
AF XY:
AC XY:
13
AN XY:
71262
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
EBV-positive nodal T- and NK-cell lymphoma Benign:1
Likely benign, no assertion criteria provided | research | Department of Clinical Pathology, School of Medicine, Fujita Health University | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at